286 related articles for article (PubMed ID: 30015870)
1. Overview of mitochondrial germline variants and mutations in human disease: Focus on breast cancer (Review).
Jiménez-Morales S; Pérez-Amado CJ; Langley E; Hidalgo-Miranda A
Int J Oncol; 2018 Sep; 53(3):923-936. PubMed ID: 30015870
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial mutations in cancer.
Brandon M; Baldi P; Wallace DC
Oncogene; 2006 Aug; 25(34):4647-62. PubMed ID: 16892079
[TBL] [Abstract][Full Text] [Related]
3. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Laurenti G; Tennant DA
Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
[TBL] [Abstract][Full Text] [Related]
4. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase.
Pollard PJ; Wortham NC; Tomlinson IP
Ann Med; 2003; 35(8):632-9. PubMed ID: 14708972
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial autoimmunity and MNRR1 in breast carcinogenesis.
Aras S; Maroun MC; Song Y; Bandyopadhyay S; Stark A; Yang ZQ; Long MP; Grossman LI; Fernández-Madrid F
BMC Cancer; 2019 May; 19(1):411. PubMed ID: 31046734
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DNA mutations and breast tumorigenesis.
Yadav N; Chandra D
Biochim Biophys Acta; 2013 Dec; 1836(2):336-44. PubMed ID: 24140413
[TBL] [Abstract][Full Text] [Related]
7. Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells.
Delsite R; Kachhap S; Anbazhagan R; Gabrielson E; Singh KK
Mol Cancer; 2002 Nov; 1():6. PubMed ID: 12495447
[TBL] [Abstract][Full Text] [Related]
8. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement.
Wallace DC
Gene; 2005 Jul; 354():169-80. PubMed ID: 16024186
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the susceptibility of mitochondrial DNA germline mutations in Chinese cancer patients.
Liu J; Xu LY; Li RL; Li EM; Kong QP
Curr Mol Med; 2014; 14(10):1265-72. PubMed ID: 25470291
[TBL] [Abstract][Full Text] [Related]
10. Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors.
De Vitto H; Mendonça BS; Elseth KM; Vesper BJ; Portari EA; Gallo CV; Paradise WA; Rumjanek FD; Radosevich JA
Tumour Biol; 2013 Feb; 34(1):337-47. PubMed ID: 23238816
[TBL] [Abstract][Full Text] [Related]
11. Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle.
Konokhova Y; Spendiff S; Jagoe RT; Aare S; Kapchinsky S; MacMillan NJ; Rozakis P; Picard M; Aubertin-Leheudre M; Pion CH; Bourbeau J; Hepple RT; Taivassalo T
Skelet Muscle; 2016; 6():10. PubMed ID: 26893822
[TBL] [Abstract][Full Text] [Related]
12. Human primitive brain displays negative mitochondrial-nuclear expression correlation of respiratory genes.
Barshad G; Blumberg A; Cohen T; Mishmar D
Genome Res; 2018 Jul; 28(7):952-967. PubMed ID: 29903725
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA mutations in Malaysian female breast cancer patients.
Omasanggar R; Yu CY; Ang GY; Emran NA; Kitan N; Baghawi A; Falparado Ahmad A; Abdullah MA; Teh LK; Maniam S
PLoS One; 2020; 15(5):e0233461. PubMed ID: 32442190
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
15. Significance of Mitochondria DNA Mutations in Diseases.
Zhu Z; Wang X
Adv Exp Med Biol; 2017; 1038():219-230. PubMed ID: 29178079
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA mutations in disease and aging.
Wallace DC
Environ Mol Mutagen; 2010 Jun; 51(5):440-50. PubMed ID: 20544884
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA, nuclear context, and the risk for carcinogenesis.
Kaufman BA; Picard M; Sondheimer N
Environ Mol Mutagen; 2019 Jun; 60(5):455-462. PubMed ID: 29332303
[TBL] [Abstract][Full Text] [Related]
19. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.
King A; Selak MA; Gottlieb E
Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081
[TBL] [Abstract][Full Text] [Related]
20. Novel non-neutral mitochondrial DNA mutations found in childhood acute lymphoblastic leukemia.
Järviaho T; Hurme-Niiranen A; Soini HK; Niinimäki R; Möttönen M; Savolainen ER; Hinttala R; Harila-Saari A; Uusimaa J
Clin Genet; 2018 Feb; 93(2):275-285. PubMed ID: 28708239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
